STING1 and cancer: In summary, we have successfully developed a synergy antitumor therapy strategy: nanozymes combined with the cGAS–STING signaling pathway agonist producing oxidative damage-mediated systemic innate immunity to remodel TEM for solid tumor S180 anti-cancer therapy.